How does inclisiran work differently?

See peer-reviewed research findings regarding "How does inclisiran work differently?" about Inclisiran (Leqvio) on this page.

How often is inclisiran injected?

See peer-reviewed research findings regarding "How often is inclisiran injected?" about Inclisiran (Leqvio) on this page.

Is inclisiran safer than PCSK9 inhibitors?

See peer-reviewed research findings regarding "Is inclisiran safer than PCSK9 inhibitors?" about Inclisiran (Leqvio) on this page.

See peer-reviewed research findings regarding "ORION trial results?" about Inclisiran (Leqvio) on this page.

Inclisiran (Leqvio): The siRNA Therapy That Silences LDL Production Twice a Year

Inclisiran is the first siRNA therapy for lipid lowering — a twice-yearly injection that silences PCSK9 synthesis in hepatocytes, sustained reduction of LDL by up to 51% (ORION-1 and ORION-10 trials).

Loading findings…

Generating research findings for

Inclisiran (Leqvio)

This takes about 10 seconds…

Research summaries are AI-generated from open-access peer-reviewed literature (PubMed Central, Cochrane, AHA/ACC). Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.